A Lancet trial found that adults who continued tirzepatide after major weight loss maintained more of their weight loss than those switched to placebo.
GLP-1 Medications and Heart Protection: What the Evidence Shows: cardiovascular outcome trial evidence, who benefits most, and how this drug class fits into.
New Research Confirms GLP-1 Medications Protect the Heart, Not Just Blood Sugar: cardiovascular outcome trial evidence, who benefits most, and how this drug.
